GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
NEW YORK, April 11, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who held shares of Blount International, Inc. (“Blount International”) (NYSE:BLT) at the close of business on March 4, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of Oregon, Portland Division. To get more information go to:
http://www.zlk.com/pslra/blount-international-inc
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that Blount International violated securities laws by issuing materials in connection with the sale of the Company to P2 Capital Partners LLC and American Securities LLC which contained material misrepresentations and omitted material information. In particular, the complaint alleges that the Proxy Statement filed in relation to the merger fails to disclose information about the Company’s financial projections as they existed earlier in the process leading up to the Buyout, thus misrepresenting and omitting information which Blount shareholders are legally entitled to in order to make a sufficiently informed vote regarding the proposed merger.
If you suffered a loss in Blount International you have until June 10, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
